Consultations

Health Canada consultations

CSHP participates in calls with Health Canada and other stakeholders (including provinces and territories, manufacturers, other healthcare associations, and group purchasing organizations). CSHP’s roles are to:

- Help determine whether the current drug shortage should be considered critical
- Share this information with members
- Help the Canadian population understand the decision-making process behind these mitigation strategies.

Draft Guidance: Accelerated Review of Human Drug Submissions
Proposed changes to the Special Access Program
Changes to the scheduling of tramadol
Health Canada proposes changes to drug regulations with respect to pharmacy practice
Pilot: Education to support mandatory reporting of serious ADR and MDI (Vanessa’s Law)
Proposed Amendments to Canada’s Food and Drug Regulations to Require the Reporting of Serious Adverse Drug Reactions by Hospitals
Monitoring of Medical Assistance in Dying Regulations